GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Post-Mkt 03-27 16:05:13 EDT

57.09

-4.26

-6.94%

盘后57.74

+0.65+1.14%

16:05 EDT

High61.12	Low55.18	Vol1.16M
Open61.12	D1 Closing61.35	Amplitude9.68%
Mkt Cap1.67B	Tradable Cap1.14B	Total Shares29.29M
T/O67.26M	T/O Rate5.82%	Tradable Shares19.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":57.09,"timestamp":1774641600000,"preClose":61.35,"halted":0,"volume":1161291,"hourTrading":{"tag":"盘后","latestPrice":57.74,"preClose":57.09,"latestTime":"16:05 EDT","volume":2558,"amount":146113.747864,"timestamp":1774641908540,"change":0.65,"changeRate":0.011386,"amplitude":0.01594},"delay":0,"changeRate":-0.0694376528117359,"floatShares":19944938,"shares":29288700,"eps":-0.733929,"marketStatus":"Post-Mkt","change":-4.26,"latestTime":"03-27 16:05:13 EDT","open":61.12,"high":61.12,"low":55.18,"amount":67259605.68636,"amplitude":0.096822,"askPrice":59,"askSize":1,"bidPrice":57,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-0.733929,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774656000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":61.35,"preHourTrading":{"tag":"盘前","latestPrice":60,"preClose":61.35,"latestTime":"09:18 EDT","volume":191,"amount":11618.65033,"timestamp":1774617538930,"change":-1.35,"changeRate":-0.022005,"amplitude":0.05216},"postHourTrading":{"tag":"盘后","latestPrice":57.74,"preClose":57.09,"latestTime":"16:05 EDT","volume":2558,"amount":146113.747864,"timestamp":1774641908540,"change":0.65,"changeRate":0.011386,"amplitude":0.01594},"volumeRatio":1.762921,"impliedVol":0.9602,"impliedVolPercentile":0.7211},"requestUrl":"/m/hq/s/WGS/wiki","defaultTab":"wiki","newsList":[{"id":"2620261657","title":"A Look At GeneDx Holdings (WGS) Valuation After Ark Buying And Zevra Genetic Testing Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2620261657","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620261657?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:06","pubTimestamp":1773860818,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics.\nSee our latest analysis for GeneDx Holdings.\nDespite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-ark-buying-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-ark-buying-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2618158347","title":"Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618158347","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618158347?lang=en_us&edition=fundamental","pubTime":"2026-03-12 23:07","pubTimestamp":1773328020,"startTime":"0","endTime":"0","summary":"Cathie Wood and Ark Invest have been snatching up shares of a small cap diagnostics company for seven straight days. Here's the stock.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/12/ARK-Invest-Photo-Cathie-Wood-3.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/12/ARK-Invest-Photo-Cathie-Wood-3.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51216368/cathie-wood-just-bought-this-small-cap-stock-seven-days-straight-should-investors-take-note","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51216368/cathie-wood-just-bought-this-small-cap-stock-seven-days-straight-should-investors-take-note","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ARKK","ISBC","ARKF","ARKQ","BK4196","BK4588","ARKX","ARKG","BK4585","BK4544","BK4211","ARKW","WGS"],"gpt_icon":0},{"id":"2618132332","title":"Analysts’ Top Healthcare Picks: GeneDx Holdings (WGS), Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618132332?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GeneDx Holdings (WGS – Research Report) and Zymework...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-genedx-holdings-wgs-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-genedx-holdings-wgs-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4196","LU0128526141.USD","ZYME","BK4137","BK4139","LU0029874061.USD","BK4581","HCSG","WGS","BK4588","BK4585","XBI","LABU"],"gpt_icon":0},{"id":"2618976452","title":"GeneDx SAVES-Kids study reports USD 80,000 average healthcare cost savings per child after exome and genome testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618976452?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:10","pubTimestamp":1773263447,"startTime":"0","endTime":"0","summary":"GeneDx reported results from its SAVES-Kids health economics analysis of whole exome and whole genome sequencing in children with neurodevelopmental disorders, including epilepsy and developmental delay or intellectual disability. The findings were presented at the ACMG Annual Meeting in Baltimore. In children with epilepsy, average total healthcare costs decreased 61% from USD 130,048 per patient per year before testing to USD 50,798 in the 12 months after testing. Among Medicaid-covered children with epilepsy, total healthcare costs decreased 53% in the year after testing, alongside 80% fewer hospitalizations. In children with developmental delay or intellectual disability, total healthcare costs decreased 19% in the first year after testing, with 80% fewer hospitalizations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL1MfGVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2618529958","title":"GeneDx to Launch Genetic Testing Program With Zevra Therapeutics to Support Patients With Suspected Niemann-Pick Disease Type C","url":"https://stock-news.laohu8.com/highlight/detail?id=2618529958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618529958?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:33","pubTimestamp":1773145987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2617505093","title":"Major Insider Moves at GeneDx Holdings Shake Up Investor Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505093","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617505093?lang=en_us&edition=fundamental","pubTime":"2026-03-06 10:11","pubTimestamp":1772763095,"startTime":"0","endTime":"0","summary":"New insider activity at GeneDx Holdings ( ($WGS) ) has taken place on March 5, 2026. Recent insider activity at GeneDx Holdings has drawn attention...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-at-genedx-holdings-shake-up-investor-buzz-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-at-genedx-holdings-shake-up-investor-buzz-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2617706155","title":"Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617706155","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617706155?lang=en_us&edition=fundamental","pubTime":"2026-03-06 08:20","pubTimestamp":1772756411,"startTime":"0","endTime":"0","summary":"Keith A. Meister, a director and 10% owner of GeneDx Holdings Corp., reported an acquisition of the company’s Class A common stock. The Form 4 was filed by Keith A. Meister, Corvex Management LP, and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL5cFGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2616325798","title":"REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs","url":"https://stock-news.laohu8.com/highlight/detail?id=2616325798","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616325798?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:00","pubTimestamp":1772546400,"startTime":"0","endTime":"0","summary":"Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services. As part of this platform, the StemRNA Clinical iPSC Seed Clone – LLF-34-F3, derived from US sourced donor material, is supported by an active FDA Drug Master File . This clone has been expanded into a GMP MCB using FDA-compliant closed system processes. This off-the-shelf GMP iPSC MCB is now available for commercial use, providing ready-to-use clinically validated starting material. For sponsors requiring European alignment, REPROCELL also offers MCB/WCB manufacturing through its partner, Histocell. This service operates with a GMP certificate and authorization from the Spanish Agency for Medicines and Medical Devices  under European Medicines Agency  oversight.US-generated StemRNA Clinical Seed Clones supported by an active FDA DMF","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2800592/REPROCELL_USA_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2800592/REPROCELL_USA_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/reprocell-launches-gmp-master-cell-bank-manufacturing-for-clinical-ipscs-302700233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BK4196","DMF","EMA.AU","WGS","BK4081","MCB","BK7129","BK4211"],"gpt_icon":0},{"id":"2616350258","title":"A Look At GeneDx Holdings (WGS) Valuation After Breakthrough Device Win And Upgraded 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616350258?lang=en_us&edition=fundamental","pubTime":"2026-03-03 01:25","pubTimestamp":1772472343,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) has just put fresh numbers on the table, reporting its full year 2025 results along with reaffirmed 2026 revenue guidance and an FDA Breakthrough Device designation for its key genomic tests.\nSee our latest analysis for GeneDx Holdings.\nDespite strong 2025 results, reaffirmed 2026 revenue guidance and the FDA Breakthrough Device designation, GeneDx’s recent share price momentum has been weak, with a 30 day share price return of 17.19% and a 90 day share price return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-breakthrough-d","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-breakthrough-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WGS"],"gpt_icon":0},{"id":"2616313193","title":"GeneDx Holdings Corp - Secures $100 Mln Term Loan - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616313193","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616313193?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:04","pubTimestamp":1772453045,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0SX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2616933135","title":"GeneDx Signs $100 Million Term Loan With Blackstone Credit and Wilmington Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2616933135","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616933135?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:03","pubTimestamp":1772453034,"startTime":"0","endTime":"0","summary":"GeneDx Holdings Corp. entered into a new $100 million term loan agreement on Feb. 27, 2026 with lenders represented by Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C., with Wilmington Trust, National Association as agent. The loan, priced at Term SOFR plus 4.50% with a 1.50% SOFR floor and maturing five years from closing, was used to repay the company’s existing term loan under its October 2023 credit agreement and is expected to support other balance sheet optimization initiatives and general corporate purposes. The facility is guaranteed by certain subsidiaries and secured by a first-lien interest in substantially all assets, and includes a $50 million minimum liquidity covenant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL81HmNY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","LU0949170772.SGD","BK4196","IE00BLSP4452.SGD","BK4211","IE00BN8TJ469.HKD","LU1668664300.SGD","IE00BGHQF748.EUR","LU0053666078.USD","IE00B3QW5Z07.USD","LU0106831901.USD","WGS","BK4588","IE00BLSP4239.USD","LU0661504455.SGD","BX","MTB","IE00B64PRP62.GBP","IE0004445239.USD","LU0738911758.USD","BK4585","LU0170899867.USD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2614044496","title":"10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2614044496","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614044496?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:00","pubTimestamp":1772110800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb.  26, 2026  (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitledOGM Making its Mark in Constitutional Gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/26/3245500/0/en/10-Presentations-on-Day-3-of-Bionano-Symposium-2026-Showcase-OGM-s-Utility-in-Unraveling-the-Complex-Puzzles-of-Constitutional-Genetic-Disorders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","ITP","BK4585","CMA","BK4199","BK4588","WGS","BK4144","BK4207","BK4589","BK4590","WES","BK4196"],"gpt_icon":0},{"id":"2614066689","title":"Halper Sadeh Probes GeneDx Holdings for Fiduciary Breaches","url":"https://stock-news.laohu8.com/highlight/detail?id=2614066689","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614066689?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:03","pubTimestamp":1772067793,"startTime":"0","endTime":"0","summary":"Halper Sadeh LLC is investigating whether certain officers and directors of GeneDx Holdings Corp. breached their fiduciary duties to shareholders. The firm urged long-term shareholders to contact it to discuss potential claims and possible remedies, including corporate governance reforms, the return of funds to the company, and other relief.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLcdqKZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2614087704","title":"GeneDx to Present at TD Cowen Annual Health Care Conference and Barclays Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614087704","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614087704?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:30","pubTimestamp":1772026256,"startTime":"0","endTime":"0","summary":"GeneDx to Present at TD Cowen Annual Health Care Conference and Barclays Global Healthcare Conference               GeneDx (Nasdaq: WGS) said its management will participate in the TD Cowen 46th Annua","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL8ly5TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2614370994","title":"Wells Fargo Reaffirms Their Buy Rating on GeneDx Holdings (WGS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614370994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614370994?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:05","pubTimestamp":1772006754,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Brandon Couillard maintained a Buy rating on GeneDx Holdings yesterday and set a price target of $155.00. The company’s shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-genedx-holdings-wgs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-genedx-holdings-wgs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS"],"gpt_icon":0},{"id":"2614074907","title":"These Analysts Slash Their Forecasts On GeneDx After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614074907","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614074907?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:40","pubTimestamp":1771954839,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50824867/these-analysts-slash-their-forecasts-on-genedx-after-q4-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"1160464456","title":"Stock Track | GeneDx Holdings Plummets 5.09% Intraday on Multiple Analyst Price Target Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=1160464456","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160464456?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:45","pubTimestamp":1771944313,"startTime":"0","endTime":"0","summary":"GeneDx Holdings Corp. (WGS) saw its stock price plummet 5.09% during intraday trading on Tuesday, reflecting significant selling pressure.The sharp decline follows a series of analyst price target...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WGS"],"gpt_icon":0},{"id":"2613136067","title":"GeneDx Holdings (WGS) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2613136067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613136067?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:37","pubTimestamp":1771933020,"startTime":"0","endTime":"0","summary":"In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on GeneDx Holdings, with a price target of $130.00. Accordi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/genedx-holdings-wgs-gets-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/genedx-holdings-wgs-gets-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2613927477","title":"GeneDx Holdings Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927477","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613927477?lang=en_us&edition=fundamental","pubTime":"2026-02-24 18:31","pubTimestamp":1771929060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 05:31 ET (10:31 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"gpt_icon":0},{"id":"2613379890","title":"U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2613379890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613379890?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:56","pubTimestamp":1771919787,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne TechnologiesFeb 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPG","DIPS","UCTT","EHAB","APO","CG","EVER","BX","KEYS","AVS","TDY","OKTG","JLL","FRPT","AVGW","NTSK","AVL","2NVD.UK","AVGU","GH","ZS","BBBY","AVGX","3NVD.UK","AXSM","SMG","AVGO","VVX","HRMY","WDAY","WHD","CRWL","DG","OKTA","SAIL","MRVL","KKR","WGS","AVGG","CRWD","LH","MNST","DPZ","NVD2.UK","NVDA","NVIW.SI","LIFE","ARES","MAX","SMTC"],"gpt_icon":1}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":-0.1596},{"period":"1month","weight":-0.2398},{"period":"3month","weight":-0.5414},{"period":"6month","weight":-0.4766},{"period":"1year","weight":-0.3639},{"period":"ytd","weight":-0.5283}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0615},{"period":"3month","weight":-0.0655},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1345},{"period":"ytd","weight":-0.054}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.104041},{"month":2,"riseRate":0.833333,"avgChangeRate":0.352675},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.1492},{"month":4,"riseRate":0.2,"avgChangeRate":-0.003121},{"month":5,"riseRate":0.4,"avgChangeRate":-0.013957},{"month":6,"riseRate":0.6,"avgChangeRate":0.029191},{"month":7,"riseRate":0.8,"avgChangeRate":0.138059},{"month":8,"riseRate":0.2,"avgChangeRate":-0.136267},{"month":9,"riseRate":0.2,"avgChangeRate":-0.072401},{"month":10,"riseRate":0.8,"avgChangeRate":0.18872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.130294},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.04765}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction